Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 164

1.

High baseline C-reactive protein levels predict partial type 2 diabetes mellitus remission after biliopancreatic diversion.

Bonaventura A, Liberale L, Carbone F, Scopinaro N, Camerini G, Papadia FS, Cordera R, Dallegri F, Adami GF, Montecucco F.

Nutr Metab Cardiovasc Dis. 2017 Feb 3. pii: S0939-4753(17)30020-0. doi: 10.1016/j.numecd.2017.01.007. [Epub ahead of print]

PMID:
28284664
2.

Do Bariatric Surgery-Related Type 2 Diabetes Remission Predictors Add Clinical Value? A Study on Asian Indian Obese Diabetics.

Praveen Raj P, Bhattacharya S, Saravana Kumar S, Sabnis SC, Parthasarathi R, Swamy PD, Palanivelu C.

Obes Surg. 2017 Feb 24. doi: 10.1007/s11695-017-2615-8. [Epub ahead of print]

PMID:
28236254
3.
4.

Substantial Decrease in Comorbidity 5 Years After Gastric Bypass: A Population-based Study From the Scandinavian Obesity Surgery Registry.

Sundbom M, Hedberg J, Marsk R, Boman L, Bylund A, Hedenbro J, Laurenius A, Lundegårdh G, Möller P, Olbers T, Ottosson J, Näslund I, Näslund E; Scandinavian Obesity Surgery Registry Study Group..

Ann Surg. 2016 Jul 15. [Epub ahead of print]

PMID:
27429019
5.

Effects of sleeve gastrectomy on insulin resistance.

Cătoi AF, Pârvu A, Mironiuc A, Galea RF, Mureşan A, Bidian C, Pop I.

Clujul Med. 2016;89(2):267-72. doi: 10.15386/cjmed-576.

6.

Outcome of bariatric surgery in patients with type 1 diabetes mellitus: our experience and review of the literature.

Rottenstreich A, Keidar A, Yuval JB, Abu-Gazala M, Khalaileh A, Elazary R.

Surg Endosc. 2016 Dec;30(12):5428-5433.

PMID:
27126622
7.

Long-Term (7 Years) Follow-Up of Roux-en-Y Gastric Bypass on Obese Adolescent Patients (<18 Years).

Vilallonga R, Himpens J, van de Vrande S.

Obes Facts. 2016;9(2):91-100. doi: 10.1159/000442758.

8.

Pharmacological Inhibition of Monoacylglycerol O-Acyltransferase 2 Improves Hyperlipidemia, Obesity, and Diabetes by Change in Intestinal Fat Utilization.

Take K, Mochida T, Maki T, Satomi Y, Hirayama M, Nakakariya M, Amano N, Adachi R, Sato K, Kitazaki T, Takekawa S.

PLoS One. 2016 Mar 3;11(3):e0150976. doi: 10.1371/journal.pone.0150976.

9.

Comparative Effects of Roux-en-Y Gastric Bypass and Sleeve Gastrectomy on Glucose Homeostasis and Incretin Hormones in Obese Type 2 Diabetic Patients: A One-Year Prospective Study.

Nosso G, Griffo E, Cotugno M, Saldalamacchia G, Lupoli R, Pacini G, Riccardi G, Angrisani L, Capaldo B.

Horm Metab Res. 2016 May;48(5):312-7. doi: 10.1055/s-0041-111505.

PMID:
26788926
10.

Weight Loss Decreases Excess Pancreatic Triacylglycerol Specifically in Type 2 Diabetes.

Steven S, Hollingsworth KG, Small PK, Woodcock SA, Pucci A, Aribisala B, Al-Mrabeh A, Daly AK, Batterham RL, Taylor R.

Diabetes Care. 2016 Jan;39(1):158-65. doi: 10.2337/dc15-0750.

PMID:
26628414
11.

Comparison of gut hormones and adipokines stimulated by glucagon test among patients with type II diabetes mellitus after metabolic surgery.

Chen YC, Inui A, Chang ES, Chen SC, Lee WJ, Chen CY.

Neuropeptides. 2016 Feb;55:39-45. doi: 10.1016/j.npep.2015.11.002.

PMID:
26621498
12.

Laparoscopic sleeve gastrectomy: More than a restrictive bariatric surgery procedure?

Benaiges D, Más-Lorenzo A, Goday A, Ramon JM, Chillarón JJ, Pedro-Botet J, Flores-Le Roux JA.

World J Gastroenterol. 2015 Nov 7;21(41):11804-14. doi: 10.3748/wjg.v21.i41.11804. Review.

13.

The effects of diet- and RYGB-induced weight loss on insulin sensitivity in obese patients with and without type 2 diabetes.

Hansen M, Lund MT, Jørgensen AL, Palsøe MK, van Hall G, Helge JW, Dela F.

Acta Diabetol. 2016 Jun;53(3):423-32. doi: 10.1007/s00592-015-0812-2.

PMID:
26496769
14.

Remission of Type 2 Diabetes Mellitus in Patients After Different Types of Bariatric Surgery: A Population-Based Cohort Study in the United Kingdom.

Yska JP, van Roon EN, de Boer A, Leufkens HG, Wilffert B, de Heide LJ, de Vries F, Lalmohamed A.

JAMA Surg. 2015 Dec;150(12):1126-33. doi: 10.1001/jamasurg.2015.2398.

PMID:
26422580
15.

Epigenetic Alterations in Human Liver From Subjects With Type 2 Diabetes in Parallel With Reduced Folate Levels.

Nilsson E, Matte A, Perfilyev A, de Mello VD, Käkelä P, Pihlajamäki J, Ling C.

J Clin Endocrinol Metab. 2015 Nov;100(11):E1491-501. doi: 10.1210/jc.2015-3204.

16.

Effect of Duodenal-Jejunal Bypass Surgery on Glycemic Control in Type 2 Diabetes: A Randomized Controlled Trial.

Petry TZ, Fabbrini E, Otoch JP, Carmona MA, Caravatto PP, Salles JE, Sarian T, Correa JL, Schiavon CA, Patterson BW, Cohen R, Klein S.

Obesity (Silver Spring). 2015 Oct;23(10):1973-9. doi: 10.1002/oby.21190.

17.

Adipose tissue mitochondrial respiration and lipolysis before and after a weight loss by diet and RYGB.

Hansen M, Lund MT, Gregers E, Kraunsøe R, Van Hall G, Helge JW, Dela F.

Obesity (Silver Spring). 2015 Oct;23(10):2022-9. doi: 10.1002/oby.21223.

18.

FGF 19 and Bile Acids Increase Following Roux-en-Y Gastric Bypass but Not After Medical Management in Patients with Type 2 Diabetes.

Sachdev S, Wang Q, Billington C, Connett J, Ahmed L, Inabnet W, Chua S, Ikramuddin S, Korner J.

Obes Surg. 2016 May;26(5):957-65. doi: 10.1007/s11695-015-1834-0.

PMID:
26259981
19.

Prediction of Diabetes Remission in Morbidly Obese Patients After Roux-en-Y Gastric Bypass.

Park JY, Kim YJ.

Obes Surg. 2016 Apr;26(4):749-56. doi: 10.1007/s11695-015-1823-3.

PMID:
26205218
20.

Effect of Sleeve Gastrectomy Plus Side-to-Side Jejunoileal Anastomosis for Type 2 Diabetes Control in an Obese Rat Model.

Wang K, Zhou X, Quach G, Lu J, Gao W, Xu A, Zhu J.

Obes Surg. 2016 Apr;26(4):797-804. doi: 10.1007/s11695-015-1811-7.

PMID:
26202420

Supplemental Content

Loading ...
Support Center